Health
Peptides Controversy: Medical Freedom vs. Patient Safety
People report adverse effects from experimental peptides, prompting Robert F. Kennedy Jr.’s organization to push for greater access despite concerns about patient safety.
Coverage timeline — 1 article
KFF Health News
People who have taken experimental peptides, such as BPC-157, complain of migraines, eye pain, fatigue, and more. Learning whether these popular but unproven drugs are to blame may become harder if Robert F. Kennedy Jr. fulfills a promise to make them more accessible.
2026-10-13 09:00 UTC